<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: regimen</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Combination antiretroviral therapy effective at reducing HIV resistance in mothers and babies</title>
   	 <description>In a clinical trial investigating mother-to-child HIV transmission in South Africa published this week in PLoS Medicine, Neil Martinson (of the Perinatal HIV Research Unit, Soweto, South Africa) and colleagues find that adding two other antiretroviral drugs to single dose nevirapine - an antiretroviral drug given to women and newborn children during labor and delivery to prevent transmission - is effective in reducing the drug resistance that nevirapine causes when used by itself. </description>
     <link>http://www.physorg.com/news175808373.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 27 Oct 2009 01:50:02 EST</pubDate>
	 <guid isPermaLink="false">news175808373</guid>
</item>
<item>
     <title>Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks</title>
   	 <description>New research led by Cindy Schwartz, MD, of Hasbro Children's Hospital has identified a new chemotherapy regimen for pediatric Hodgkin lymphoma (HL) patients. The new treatment enhances efficacy through dose-dense drug delivery while simultaneously reducing the long-term risks presented by high cumulative dose chemotherapy. Schwartz and the researchers of the Children's Oncology Group have published their findings in the journal Blood (posted in an online first edition).</description>
     <link>http://www.physorg.com/news166717553.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 13 Jul 2009 15:26:19 EST</pubDate>
	 <guid isPermaLink="false">news166717553</guid>
</item>
<item>
     <title>NIAID will not move forward with the PAVE 100 HIV Vaccine Trial</title>
   	 <description>After soliciting and considering broad input from the scientific and HIV advocacy communities, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has determined that it will not conduct the HIV vaccine study known as PAVE 100. </description>
     <link>http://www.physorg.com/news135509645.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 17 Jul 2008 10:34:05 EST</pubDate>
	 <guid isPermaLink="false">news135509645</guid>
</item>
<item>
     <title>Researchers uncover benefits of aspirin for treating osteoporosis</title>
   	 <description>Researchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis.  Forty-four million Americans, 68 percent of whom are women, suffer from the debilitating effects of osteoporosis according to the National Institute of Health.  One out of every two women and one in four men over 50 will have an osteoporosis-related fracture in their lifetime.</description>
     <link>http://www.physorg.com/news134819508.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 09 Jul 2008 10:51:48 EST</pubDate>
	 <guid isPermaLink="false">news134819508</guid>
</item>
<item>
     <title>New treatment approach promising for lymphoma patients in the developing world</title>
   	 <description>Preliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.</description>
     <link>http://www.physorg.com/news134542467.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 06 Jul 2008 05:54:27 EST</pubDate>
	 <guid isPermaLink="false">news134542467</guid>
</item>


</channel>
</rss>

